top of page

CONTIN         S
Solutions

CONTINUUS offers breakthrough Integrated Continuous Manufacturing solutions for the manufacturing of small molecule drugs, providing advantages across the entire supply chain.

Different solutions for different challenges

Over the past decade, many pharmaceutical companies have developed and implemented continuous manufacturing technologies. However, these efforts are very different in nature and scope with varying degrees of risks and benefits.

Risk reward_Websiter.png

About CONTINUUS Pharma

CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. We specialize in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale.

A Trusted Choice

CONTINUUS collaborates with government agencies and leading global companies within the pharmaceutical industry.

bottom of page